← FDA DRUG APPROVALS

FDA ANDA · ANDA087770

SULFINPYRAZONE

Sponsor: IVAX PHARMS

APPLICATION
ANDA087770
TYPE
ANDA
ORIGINAL APPROVAL
1982-11-19
LATEST ACTION
2000-01-28
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

SULFINPYRAZONEDiscontinued
SULFINPYRAZONE 200MG · CAPSULE · ORAL

Approval history

2000-01-28Manufacturing (CMC) · Supplement 15AP
1999-11-23Manufacturing (CMC) · Supplement 14AP
1999-08-20Manufacturing (CMC) · Supplement 13AP
1998-12-09Manufacturing (CMC) · Supplement 12AP
1997-05-30Manufacturing (CMC) · Supplement 11AP
1996-04-12Manufacturing (CMC) · Supplement 9AP
1995-01-06Labeling · Supplement 10AP
1993-04-28Manufacturing (CMC) · Supplement 8AP
1991-09-16Labeling · Supplement 7AP
1991-01-25Manufacturing (CMC) · Supplement 6AP
1991-01-25Manufacturing (CMC) · Supplement 5AP
1988-01-26Manufacturing (CMC) · Supplement 4AP
1982-11-19OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →